Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Masashi Shimabukuro
Institution:
Tokyo Metropolitan Komagome Hospital
Observed institution:
Tokyo Metropolitan Komagome Hospital
ORCID:
0000-0003-4882-9873
Observed ORCID:
0000-0003-4882-9873
OpenAlex ID:
A5087819309
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission Status
2023
·
Takaaki Konuma
, Satoshi Yamasaki
, et al.
·
Transplantation and Cellular Therapy
·
24
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience
2025
·
Yusuke Uchibori
, Shuhei Kurosawa
, et al.
·
Frontiers in Immunology
·
12
PDF
Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation
2025
·
Kazuya Kurihara
, Daichi Sadato
, et al.
·
Transplantation and Cellular Therapy
·
8
Real‐World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients
2025
·
Yasutaka Masuda
, Takashi Toya
, et al.
·
Transplant Infectious Disease
·
7
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center
2025
·
Shuhei Kurosawa
, Kairi Kojo
, et al.
·
Bone Marrow Transplantation
·
7
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults
2025
·
Kaori Kondo
, Yuho Najima
, et al.
·
Leukemia Research
·
4
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia
2024
·
Fumihiko Ouchi
, Naoki Shingai
, et al.
·
International Journal of Hematology
·
4
Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era
2026
·
Atsushi Jinguji
, Shuhei Kurosawa
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study
2025
·
Shuhei Kurosawa
, Kana Kato
, et al.
·
Japanese Journal of Thrombosis and Hemostasis
·
3
PDF
Real‐World Practice and Challenges of Donor Lymphocyte Apheresis and Infusion: A Single‐Center Experience
2025
·
Shuhei Kurosawa
, Kyoko Haraguchi
, et al.
·
Therapeutic Apheresis and Dialysis
·
3
Impact of stem cell selection between bone marrow and peripheral blood stem cells for unrelated hematopoietic stem cell transplantation for hematologic malignancies: on behalf of the Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy
2023
·
Hiromi Hayashi
, Makoto Iwasaki
, et al.
·
Cytotherapy
·
3
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation
2023
·
Naoki Shingai
, Akihito Ota
, et al.
·
Transplantation and Cellular Therapy
·
3
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation
2025
·
Yasutaka Sadaga
, Daisuke Watanabe
, et al.
·
Hematology
·
2
Drug‐induced liver injury due to granulocyte colony‐stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation
2025
·
Kana Kato
, Shuhei Kurosawa
, et al.
·
Vox Sanguinis
·
1
Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapy
2024
·
Yoshimitsu Shimomura
, Tetsuhisa Kitamura
, et al.
·
Bone Marrow Transplantation
·
1
Clinical impact of infused CD3-positive cell dose in unrelated peripheral blood stem cell transplantation
2026
·
Yasutaka Sadaga
, Shuhei Kurosawa
, et al.
·
International Journal of Hematology
Peripheral Neuropathy After Allogeneic Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, and Electrophysiologic Features
2026
·
Shuhei Kurosawa
, Yukie Ishizaka
, et al.
·
Transplantation and Cellular Therapy
Case Report: Immune-driven clonal selection underlying lineage switch from B-Precursor acute lymphoblastic leukemia to acute myeloid leukemia following inotuzumab ozogamicin
2026
·
Kaori Kondo
, Daichi Sadato
, et al.
·
Frontiers in Immunology
PDF
Chronic neutrophilic leukemia with transformation to B-lymphoblastic leukemia
2026
·
Junichi Mukae
, Daichi Sadato
, et al.
·
Leukemia Research
Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation
2026
·
Ryo Hasunuma
, Hiroaki Shimizu
, et al.
·
Transplantation and Cellular Therapy
[Clinical outcomes of idecabtagene vicleucel therapy for relapsed/refractory multiple myeloma: a single-center retrospective analysis].
2026
·
Kairi Kojo
, Yuho Najima
, et al.
·
PubMed
[Diagnostic utility of small-bowel capsule endoscopy in patients with gastrointestinal symptoms after allogeneic hematopoietic cell transplantation].
2026
·
Satomi Shibata
, Atsushi Jinguji
, et al.
·
PubMed
Real-world Practice and Challenges of Donor Lymphocyte Apheresis and Infusion: a Single-center Experience
2025
·
Shuhei Kurosawa
, Kyoko Haraguchi
, et al.
·
Japanese Journal of Transfusion and Cell Therapy
PDF
TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT
2025
·
Kairi Kojo
, Hiroaki Shimizu
, et al.
·
Blood
PDF
Poor neutrophil recovery following CD19-targeted CAR-T cell therapy predicts inferior outcomes in adult patients with B-cell lymphoma
2025
·
Hiroaki Shimizu
, Satoshi Koi
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
30
Citation count:
85
H-index:
5
I10-index:
2
Year
Topic
Type